rs58163069
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000424.4(KRT5):c.519G>C(p.Lys173Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000424.4 missense
Scores
Clinical Significance
Conservation
Publications
- Dowling-Degos diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- epidermolysis bullosa simplex 1A, generalized severeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics
- epidermolysis bullosa simplex 2F, with mottled pigmentationInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia, G2P
- Dowling-Degos disease 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- epidermolysis bullosa simplex 1B, generalized intermediateInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- epidermolysis bullosa simplex 1C, localizedInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- epidermolysis bullosa simplex 2B, generalized intermediateInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: PanelApp Australia
- epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- epidermolysis bullosa simplex 2E, with migratory circinate erythemaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
- -
For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRT5 protein function. ClinVar contains an entry for this variant (Variation ID: 14643). This missense change has been observed in individual(s) with autosomal dominant epidermolysis bullosa simplex (PMID: 7534039). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with asparagine at codon 173 of the KRT5 protein (p.Lys173Asn). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and asparagine. -
Epidermolysis bullosa simplex 2B, generalized intermediate Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at